| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Paraic A Kenny | |
| P2860 | cites work | Mutations of the BRAF gene in human cancer | Q27860760 |
| P433 | issue | 9 | |
| P304 | page(s) | 800-808 | |
| P577 | publication date | 2007-07-02 | |
| P1433 | published in | Differentiation | Q4847340 |
| P1476 | title | TACE: a new target in epidermal growth factor receptor dependent tumors | |
| P478 | volume | 75 |
| Q41980551 | A disintegrin and metalloprotease (ADAM) 10 and ADAM17 are major sheddases of T cell immunoglobulin and mucin domain 3 (Tim-3) |
| Q39363398 | A novel bispecific single-chain antibody for ADAM17 and CD3 induces T-cell-mediated lysis of prostate cancer cells |
| Q38965918 | ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion |
| Q52584359 | ADAM17 inhibition enhances platinum efficiency in ovarian cancer. |
| Q37398747 | ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation |
| Q39561009 | ADAM17 promotes glioma cell malignant phenotype |
| Q39241466 | Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors |
| Q46066628 | Clarification of the C-terminal proteolytic processing site of human Amphiregulin. |
| Q34044458 | Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice |
| Q30499696 | Cross-domain inhibition of TACE ectodomain |
| Q38949261 | Dihydroartemisinin suppresses glioma proliferation and invasion via inhibition of the ADAM17 pathway |
| Q39067520 | Effects of tetrandrine on glioma cell malignant phenotype via inhibition of ADAM17. |
| Q54385982 | Estrogen signalling through amphiregulin may be implicated in human hepatocellular carcinoma. |
| Q47153170 | Expression of the antiapoptotic protein survivin in colon cancer |
| Q42152278 | Expression of tumor necrosis factor-alpha converting enzyme in liver regeneration after partial hepatectomy |
| Q39645443 | Free energy calculations on snake venom metalloproteinase BaP1. |
| Q37352425 | High shed antigen levels within tumors: an additional barrier to immunoconjugate therapy |
| Q35071481 | In vivo invasion of head and neck squamous cell carcinoma cells does not require macrophages |
| Q42042162 | LPS increases MUC5AC by TACE/TGF-α/EGFR pathway in human intrahepatic biliary epithelial cell |
| Q37904866 | Lessons from common markers of tumor-initiating cells in solid cancers |
| Q35990316 | Mesenchymal Stem Cells Shed Amphiregulin at the Surface of Lung Carcinoma Cells in a Juxtacrine Manner. |
| Q37620891 | Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer |
| Q41017172 | Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling |
| Q37658849 | Novel TACE inhibitors in drug discovery: a review of patented compounds |
| Q24315870 | Nuclear signalling by tumour-associated antigen EpCAM |
| Q35073341 | Overexpression of miR‑145 in U87 cells reduces glioma cell malignant phenotype and promotes survival after in vivo implantation |
| Q26775602 | Recent advances in the field of anti-cancer immunotherapy |
| Q49378719 | Short hairpin RNA-mediated gene silencing of ADAM17 inhibits the growth of breast cancer MCF‑7 cells in vitro and in vivo and its mechanism of action |
| Q47156836 | Soluble TNF Regulates TACE via AP-2α Transcription Factor in Mouse Dendritic Cells |
| Q37663864 | TACE-dependent TGFα shedding drives triple-negative breast cancer cell invasion |
| Q39584576 | TGF-β1 promotes motility and invasiveness of glioma cells through activation of ADAM17. |
| Q39276410 | The EGF receptor and HER2 participate in TNF-α-dependent MAPK activation and IL-8 secretion in intestinal epithelial cells |
| Q38961857 | The role of ADAM17 in tumorigenesis and progression of breast cancer |
| Q28473677 | Unraveling the microenvironmental influences on the normal mammary gland and breast cancer |
| Q34296399 | Variability in melanoma metalloproteinase expression profiling |
Search more.